References
Massarweh SA, Sledge GW, Miller DP, McCullough D, Petkov VI, Shak S. Molecular characterization and mortality from breast cancer in men. J Clin Oncol. 2018;36:1396–404.
Giordano SH. Breast cancer in men. N Engl J Med. 2018;378:2311–20.
Greif JM, Pezzi CM, Klimberg VS, Bailey L, Zuraek M. Gender differences in breast cancer: analysis of 13,000 breast cancers in men from the National Cancer Data Base. Ann Surg Oncol. 2012;19:3199–204.
Grenader T, Yerushalmi R, Tokar M, et al. The 21-gene recurrence score assay (Oncotype DX™) in estrogen receptor-positive male breast cancer: experience in an Israeli cohort. Oncology. 2014;87:1–6.
Altman AM, Kizy S, Yuan J, et al. Distribution of 21-gene recurrence scores in male breast cancer in the United States. Ann Surg Oncol. 2018;25:2296–302.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The authors have no conflicts of interest to disclose.
Additional information
ASO Author Reflections offer a brief invited commentary on the article, "Distribution of 21-Gene Recurrence Scores in Male Breast Cancer in the United States," Ann Surg Oncol. 2018; 25: 2296–302.
Rights and permissions
About this article
Cite this article
Altman, A.M., Marmor, S. ASO Author Reflections: 21-Gene Recurrence Scores in Male Breast Cancer. Ann Surg Oncol 25 (Suppl 3), 669–670 (2018). https://doi.org/10.1245/s10434-018-6951-2
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-018-6951-2